187 related articles for article (PubMed ID: 17940746)
1. Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials.
Niël-Weise BS; Stijnen T; van den Broek PJ
Intensive Care Med; 2007 Dec; 33(12):2058-68. PubMed ID: 17940746
[TBL] [Abstract][Full Text] [Related]
2. Anti-infective-treated central venous catheters for total parenteral nutrition or chemotherapy: a systematic review.
Niël-Weise BS; Stijnen T; van den Broek PJ
J Hosp Infect; 2008 Jun; 69(2):114-23. PubMed ID: 18439717
[TBL] [Abstract][Full Text] [Related]
3. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.
Hockenhull JC; Dwan K; Boland A; Smith G; Bagust A; Dündar Y; Gamble C; McLeod C; Walley T; Dickson R
Health Technol Assess; 2008 Apr; 12(12):iii-iv, xi-xii, 1-154. PubMed ID: 18405471
[TBL] [Abstract][Full Text] [Related]
4. The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: a systematic review.
Hockenhull JC; Dwan KM; Smith GW; Gamble CL; Boland A; Walley TJ; Dickson RC
Crit Care Med; 2009 Feb; 37(2):702-12. PubMed ID: 19114884
[TBL] [Abstract][Full Text] [Related]
5. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
Cochrane Database Syst Rev; 2013 Jun; (6):CD007878. PubMed ID: 23740696
[TBL] [Abstract][Full Text] [Related]
6. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis.
Walder B; Pittet D; Tramèr MR
Infect Control Hosp Epidemiol; 2002 Dec; 23(12):748-56. PubMed ID: 12517018
[TBL] [Abstract][Full Text] [Related]
7. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials.
Falagas ME; Fragoulis K; Bliziotis IA; Chatzinikolaou I
J Antimicrob Chemother; 2007 Mar; 59(3):359-69. PubMed ID: 17255143
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis.
Casey AL; Mermel LA; Nightingale P; Elliott TS
Lancet Infect Dis; 2008 Dec; 8(12):763-76. PubMed ID: 19022192
[TBL] [Abstract][Full Text] [Related]
9. The safety of prolonging the use of central venous catheters: a prospective analysis of the effects of using antiseptic-bonded catheters with daily site care.
Norwood S; Wilkins HE; Vallina VL; Fernandez LG; McLarty JW
Crit Care Med; 2000 May; 28(5):1376-82. PubMed ID: 10834681
[TBL] [Abstract][Full Text] [Related]
10. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
11. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units.
Ramritu P; Halton K; Collignon P; Cook D; Fraenkel D; Battistutta D; Whitby M; Graves N
Am J Infect Control; 2008 Mar; 36(2):104-17. PubMed ID: 18313512
[TBL] [Abstract][Full Text] [Related]
12. Effect of skin antiseptic solutions on the incidence of catheter-related bloodstream infection: a systematic review and network meta-analysis.
Masuyama T; Yasuda H; Sanui M; Lefor AK
J Hosp Infect; 2021 Apr; 110():156-164. PubMed ID: 33529623
[TBL] [Abstract][Full Text] [Related]
13. Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly.
Lorente L; Lecuona M; Jiménez A; Raja L; Cabrera J; Gonzalez O; Diosdado S; Marca L; Mora ML
Am J Infect Control; 2016 Jan; 44(1):50-3. PubMed ID: 26412482
[TBL] [Abstract][Full Text] [Related]
14. New choices for central venous catheters: potential financial implications.
Shorr AF; Humphreys CW; Helman DL
Chest; 2003 Jul; 124(1):275-84. PubMed ID: 12853534
[TBL] [Abstract][Full Text] [Related]
15. Taurolidine lock solution for catheter-related bloodstream infections in pediatric patients: A meta-analysis.
Sun Y; Wan G; Liang L
PLoS One; 2020; 15(4):e0231110. PubMed ID: 32255798
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis.
Wang H; Huang T; Jing J; Jin J; Wang P; Yang M; Cui W; Zheng Y; Shen H
J Hosp Infect; 2010 Sep; 76(1):1-11. PubMed ID: 20638155
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials.
Snaterse M; Rüger W; Scholte Op Reimer WJ; Lucas C
J Hosp Infect; 2010 May; 75(1):1-11. PubMed ID: 20227787
[TBL] [Abstract][Full Text] [Related]
18. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial.
León C; Ruiz-Santana S; Rello J; de la Torre MV; Vallés J; Alvarez-Lerma F; Sierra R; Saavedra P; Alvarez-Salgado F;
Intensive Care Med; 2004 Oct; 30(10):1891-9. PubMed ID: 15278273
[TBL] [Abstract][Full Text] [Related]
19. Heparin-bonded catheters for prolonging the patency of central venous catheters in children.
Shah PS; Shah N
Cochrane Database Syst Rev; 2007 Oct; (4):CD005983. PubMed ID: 17943871
[TBL] [Abstract][Full Text] [Related]
20. Rates of infection for single-lumen versus multilumen central venous catheters: a meta-analysis.
Dezfulian C; Lavelle J; Nallamothu BK; Kaufman SR; Saint S
Crit Care Med; 2003 Sep; 31(9):2385-90. PubMed ID: 14501971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
